The Arts and Humanities Research Council (AHRC), working in collaboration with other Research Councils within UKRI, is planning to announce a new funding call in early 2020 for Partnership Development awards under the Global Challenges Research Fund’s Collective Programme. This call will support the development of equitable partnerships and an interdisciplinary community to explore the intersections between conflict and fragility (SDG 16: Peace, Justice and Strong Institutions & GCRF Conflict portfolio) and wider development challenges (and other SDGs and GCRF portfolios) such as health, environmental resilience, sustainable cities and food systems, as well as cross-cutting development issues such as gender, inequalities, poverty reduction and sustainable livelihoods.
The call will launch in early March 2020 with a closing date in late spring 2020 and projects expected to start from autumn 2020. Approximately 20 awards of varying sizes up to £200,000 (fEC) and between 12 and 24 months duration will be supported.
Further details can be found in this Pre-Call Announcement Document (PDF, 172KB)
Timescale
| Call opens | February/March 2020 |
| Call Close | May 2020 |
| Panel | July 2020 |
| Expected grant start dates | September/October 2020 |
If you require further information, please don’t hesitate to contact Alex Pekalski. She’s happy to have a chat with prospective applicants.
GCRF Collective Programme Pre- Call Announcements
RCUK GCRF Call for Evidence










3C Event: Research Culture, Community & Cookies – Tuesday 13 January 10-11am
Dr. Chloe Casey on Sky News
Final Bournemouth University publication of 2025
On Christmas Day in the Morning…
New Nepal scoping review on maternal & neonatal health
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease